Sustainable Insight Capital Management, LLC Amgen Inc Transaction History

Sustainable Insight Capital Management, LLC

$199 Million
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $93,898 - $104,493	-407 Reduced 29.41%	977 $242,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.07%	1,384 $335,000
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $86,115 - $98,550	-433 Reduced 23.84%	1,383 $311,000
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $21,439 - $25,118	101 Added 5.89%	1,816 $386,000
Q2 2021 Aug 10, 2021	BUY	$233.58 - $259.14 $28,029 - $31,096	120 Added 7.52%	1,715 $418,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $23,522 - $27,411	-106 Reduced 6.23%	1,595 $397,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $149,302 - $177,792	690 Added 68.25%	1,701 $391,000
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $191,291 - $245,875	1,011 New	1,011 $244,000
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $193,436 - $231,776	-1,111 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $66,680 - $78,164	-400 Reduced 26.47%	1,111 $205,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $3,979 - $4,485	-22 Reduced 1.44%	1,511 $287,000
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $1.19 Million - $1.34 Million	-6,401 Reduced 80.68%	1,533 $318,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $719,660 - $808,334	4,334 Added 120.39%	7,934 $1.47 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $609,948 - $712,800	3,600 New	3,600 $614,000

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sustainable Insight Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sustainable Insight Capital Management, LLC with notifications on news.

Account